Abstract:Objective:To investigate the effect of Roux-en-Y gastric bypass (RYGB) on the hepatic bile acids signaling and gluconeogenesis in type 2 diabetes mellitus (T2DM) rats.Methods:A total of 16 Sprague-Dawley male rats were fed on a high-fat diet and injected intraperitoneally with streptozotocin to induce T2DM, then all rats were randomly divided into sham surgery group ( n=8) and RYGB group ( n=8). RYGB surgery was performed in RYGB group, sham surgeries involved the same gastrointestinal transections as those in the RYGB group, and re-anastomosis was performed at the same sites. Fasting blood glucose levels and food intake were measured before and 1st, 2nd, 4th, 6th, 8th week after surgery. Oral glucose tolerance test (OGTT) and insulin tolerance test (ITT) were performed preoperatively and at 2nd and 8th week postoperatively. At 8th week postoperatively, the fasting serum bile acids levels were measured and hepatic tissues were taken to compare the mRNA expression of farnesoid X receptor (FXR), small heterodimeric partner (SHP), phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase) by reverse transcriptase-polymerase chain reaction. Results:At 4th, 6th, 8th week postoperatively, the food intake in RYGB group [(18±2), (19±3), (20±4) g/d] was decreased as compared with sham surgery group [(24±3), (28±4), (26±3) g/d]; At 2nd, 4th, 6th and 8th week postoperatively, the fasting blood glucose levels in RYGB group [(6.9±0.9), (6.0±1.1), (6.4±0.8), (6.8±0.7) mmol/L] were decreased as compared with sham surgery group [(12.9±1.4), (10.8±0.8), (9.4±1.1), (9.0±1.0) mmol/L], with significant differences ( t=4.707, 5.091, 3.394, 9.209, 9.982, 6.239, 5.098, P<0.05); On postoperative week 2, the areas under the curve of OGTT and ITT in RYGB group [(898±118), (428±85) mmol/ (L·min)] were decreased compared with sham surgery group [(1 508±108), (788±98) mmol/ (L·min)]; On postoperative week 8, the areas under the curve of OGTT and ITT in RYGB group [(975±102), (455±76) mmol/ (L·min) ] were decreased as compared with sham surgery group [(1 575±96), (775±86) mmol/ (L·min) ], with significant differences ( t=10.790, 7.849, 12.120, 7.886, P<0.05); On postoperative week 8, the serum total bile acids level in RYGB group [(105.17±14.81) μmol/L] was increased as compared with sham surgery group [(68.87±10.81) μmol/L], with significant differences ( t=5.600, P<0.05); As compared with sham surgery group, the hepatic mRNA expression of FXR and SHP in RYGB group was up-regulated (1.67±0.31 vs. 1.17±0.11, 2.37±0.21 vs. 1.33±0.18), the hepatic mRNA expression of PEPCK and G6Pase in RYGB group was down-regulated (0.77±0.12 vs. 1.15±0.14, 0.87±0.08 vs. 1.05±0.10), with significant differences ( t=4.299, 10.640, 5.829, 3.976, P<0.05). Conclusion:RYGB can improve the glucose metabolism in T2DM rats, which may be related with increased hepatic bile acids signaling and decreased gluconeogenesis.

Gastric bypass surgery is protective from high-fat diet-induced non-alcoholic fatty liver disease and hepatic endoplasmic reticulum stress

Effect of Roux-en-Y Gastric Bypass Surgery on Hepatic Glucolipid Metabolism in Rats with Obesity Combined with Type 2 Diabetes Mellitus

Roux-en-Y Gastric Bypass in Obese Diabetic Rats Promotes Autophagy to Improve Lipid Metabolism through mTOR/p70S6K Signaling Pathway

Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.

RYGB Increases Postprandial Gastric Nesfatin-1 and Rapid Relieves NAFLD Via Gastric Nerve Detachment.

Effect of Roux-en-Y gastric bypass on the hepatic bile acids signaling and gluconeogenesis in type 2 diabetic rats

RYGB Is More Effective than VSG at Protecting Mice from Prolonged High-Fat Diet Exposure: An Occasion to Roll Up Our Sleeves?

Impact of gastric bypass surgery on the liver fibrosis of patients with extreme obesity and nonalcoholic fatty liver disease in 30-month follow-up

Reversal of NAFLD After VSG Is Independent of Weight-Loss but RYGB Offers More Efficacy When Maintained on a High-Fat Diet

Roux-en-Y Gastric Bypass Surgery Suppresses Hepatic Gluconeogenesis and Increases Intestinal Gluconeogenesis in a T2DM Rat Model.

Roux-en-Y Gastric Bypass Surgery is Effective in Fibroblast Growth Factor-21 Deficient Mice

Impact of bariatric surgery on glucose and lipid metabolism and liver and kidney function in food-induced obese diabetic rats

Gastric Bypass Increases Circulating Bile Acids and Activates Hepatic Farnesoid X Receptor (FXR) but Requires Intact Peroxisome Proliferator Activator Receptor Alpha (PPARα) Signaling to Significantly Reduce Liver Fat Content

Changes of Serum Lipopolysaccharide, Inflammatory Factors, and Cecal Microbiota in Obese Rats with Type 2 Diabetes Induced by Roux-en-Y Gastric Bypass

Unlike calorie restriction, Roux-en-Y gastric bypass surgery does not increase hypothalamic AgRP and NPY in mice on a high-fat diet

Increased Energy Expenditure and Energy Loss Through Feces Contribute to the Long-Term Outcome of Roux-en-Y Gastric Bypass in a Diet-Induced Obese Mouse Model

Combined loss of GLP-1R and Y2R does not alter progression of high-fat diet-induced obesity or response to RYGB surgery in mice

Gastric Bypass Surgery Alters the Mechanisms of Insulin Resistance in the Adipose Tissue of Gk Rats

Roux-en-Y gastric bypass-induced perturbative changes in microbial communities and metabolic pathways in rats

Roux-en-Y Gastric Bypass Improved Insulin Resistance Via Alteration of the Human Gut Microbiome and Alleviation of Endotoxemia